Skip to main content

Published locations for Value of alemtuzumab demonstrated in RRMS patients with prior IFNB-1a treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Value of alemtuzumab demonstrated in RRMS patients with prior IFNB-1a treatment

User login

  • Reset your password
  • /content/value-alemtuzumab-demonstrated-rrms-patients-prior-ifnb-1a-treatment
  • /multiplesclerosishub/article/167049/multiple-sclerosis/value-alemtuzumab-demonstrated-rrms-patients
  • /neurology/article/167049/multiple-sclerosis/value-alemtuzumab-demonstrated-rrms-patients-prior-ifnb
  • /neurology/msresourcecenter/article/167049/multiple-sclerosis/value-alemtuzumab-demonstrated-rrms
  • /breast-cancer-icymi/article/167049/multiple-sclerosis/value-alemtuzumab-demonstrated-rrms-patients
  • /b-cell-lymphoma-icymi/article/167049/multiple-sclerosis/value-alemtuzumab-demonstrated-rrms-patients
  • /clinicalneurologynews/article/167049/multiple-sclerosis/value-alemtuzumab-demonstrated-rrms-patients